Literature DB >> 33239729

PARP inhibitors coming of age.

Shani Paluch-Shimon1, Fatima Cardoso2.   

Abstract

Entities:  

Year:  2021        PMID： 33239729     DOI： 10.1038/s41571-020-00452-2

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5).

Authors:  F Cardoso; S Paluch-Shimon; E Senkus; G Curigliano; M S Aapro; F André; C H Barrios; J Bergh; G S Bhattacharyya; L Biganzoli; F Boyle; M-J Cardoso; L A Carey; J Cortés; N S El Saghir; M Elzayat; A Eniu; L Fallowfield; P A Francis; K Gelmon; J Gligorov; R Haidinger; N Harbeck; X Hu; B Kaufman; R Kaur; B E Kiely; S-B Kim; N U Lin; S A Mertz; S Neciosup; B V Offersen; S Ohno; O Pagani; A Prat; F Penault-Llorca; H S Rugo; G W Sledge; C Thomssen; D A Vorobiof; T Wiseman; B Xu; L Norton; A Costa; E P Winer
Journal:  Ann Oncol       Date:  2020-09-23       Impact factor: 32.976
  1 in total
  7 in total

Review 1.  Targeting oncogene and non-oncogene addiction to inflame the tumour microenvironment.

Authors:  Giulia Petroni; Aitziber Buqué; Lisa M Coussens; Lorenzo Galluzzi
Journal:  Nat Rev Drug Discov       Date:  2022-03-15       Impact factor: 84.694

Review 2.  Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer.

Authors:  Giulia Petroni; Lewis C Cantley; Laura Santambrogio; Silvia C Formenti; Lorenzo Galluzzi
Journal:  Nat Rev Clin Oncol       Date:  2021-11-24       Impact factor: 66.675

3.  Olaparib Induces RPL5/RPL11-Dependent p53 Activation via Nucleolar Stress.

Authors:  Tao Han; Jing Tong; Mengxin Wang; Yu Gan; Bo Gao; Jiaxiang Chen; Youxun Liu; Qian Hao; Xiang Zhou
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

Review 4.  Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules.

Authors:  Maria Giulia Nizi; Mirko M Maksimainen; Lari Lehtiö; Oriana Tabarrini
Journal:  J Med Chem       Date:  2022-05-24       Impact factor: 8.039

5.  A renal cell carcinoma tumorgraft platform to advance precision medicine.

Authors:  Roy Elias; Vanina T Tcheuyap; Akash K Kaushik; Nirmish Singla; Ming Gao; Oscar Reig Torras; Alana Christie; Aditi Mulgaonkar; Layton Woolford; Christina Stevens; Kavitha Priya Kettimuthu; Andrea Pavia-Jimenez; Lindsey K Boroughs; Allison Joyce; Marianna Dakanali; Hollis Notgrass; Vitaly Margulis; Jeffrey A Cadeddu; Ivan Pedrosa; Noelle S Williams; Xiankai Sun; Ralph J DeBerardinis; Orhan K Öz; Hua Zhong; Somasekar Seshagiri; Zora Modrusan; Brandi L Cantarel; Payal Kapur; James Brugarolas
Journal:  Cell Rep       Date:  2021-11-23       Impact factor: 9.995

6.  A Novel PARP Inhibitor YHP-836 For the Treatment of BRCA-Deficiency Cancers.

Authors:  Tingting Du; Zhihui Zhang; Jie Zhou; Li Sheng; Haiping Yao; Ming Ji; Bailing Xu; Xiaoguang Chen
Journal:  Front Pharmacol       Date:  2022-07-13       Impact factor: 5.988

Review 7.  Intersection of Two Checkpoints: Could Inhibiting the DNA Damage Response Checkpoint Rescue Immune Checkpoint-Refractory Cancer?

Authors:  Peter H Goff; Rashmi Bhakuni; Thomas Pulliam; Jung Hyun Lee; Evan T Hall; Paul Nghiem
Journal:  Cancers (Basel)       Date:  2021-07-08       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.